Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AstraZeneca PLC

http://www.astrazeneca.com

Latest From AstraZeneca PLC

As Biopharma Seeks Broader IRA Orphan Exclusion, Study Urges Boosting Savings By Eliminating It

Research takes deep dive into the implications around exempting certain orphan drugs that may qualify for the Inflation Reduction Act’s Medicare price negotiation program, including the effect of the exemption on Medicare spending and the revenue potential of those drugs.

Rare Diseases Pricing Debate

J&J In Immunology: “We Plan To Lead The Orals Market”

Immune Disorders Business Strategies

Novartis’s Fabhalta Reaches First Stop On Regulatory Journey With PNH Nod

Novartis envisions the drug, the first oral monotherapy for PNH, as a “pipeline in a pill” that could see $3bn in peak sales, with a Phase III readout in IgAN in October and one in C3G expected this month.

Approvals Blood & Coagulation Disorders

AstraZeneca Likes What Chinese Innovation Has To Offer

Chinese drugmakers’ “ability to move quicker at pace and with purpose” than counterparts in the US, Europe and other parts of the world underlies increasing deal activity with big pharmas, AstraZeneca’s BD chief Shaun Grady tells Scrip

China Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Alexion Pharmaceuticals Inc.
    • Almirall Sofotec
    • AlphaCore Pharma
    • Amplimmune, Inc.
    • Ardea Biosciences, Inc.
    • Arrow Therapeutics
    • Aviron
    • Cellective Therapeutics, Inc.
    • Definiens
    • IntraBiotics Pharmaceuticals, Inc.
    • KuDOS Pharmaceuticals Ltd.
    • Medimmune
    • Novexel
    • Neogene Therapeutics, Inc.
    • Omthera Pharmaceuticals
    • Pearl Therapeutics
    • Spirogen Ltd.
    • TeneoTwo, Inc.
    • U.S. Bioscience
    • Acerta Pharma
    • ZS Pharma
UsernamePublicRestriction

Register